Subscribe or Manage Preferences
VBCR - December 2015, Volume 4, No 6 - Value Propositions

As the healthcare system in the United States moves slowly toward a value-based strategy, a recent online article noted that value-based care can lower costs and is certainly beneficial for insurers, including Medicare, but asked, “...does it bring benefits to physicians or patients?” Answers to that question varied for large and small practices, physicians employed by hospitals, and specialists, and were influenced by other payment systems in use, such as pay for performance, bundled payments, and participation in accountable care organizations (ACOs).

Most physicians currently practice on a fee-for-service model, and the transition to value-based payments will take time and effort. James Holly, MD, is CEO of Southeast Texas Medical Associates, a multispecialty practice with 50 providers in Beaumont. He reports using value-based approaches for almost 20 years and advises practitioners to speed up the shift. But this group employs 6 people to manage its information technology (IT) system, which was built over the past 18 years at a cost of more than $9.5 million.

Although some physicians have begun to receive income from value-based programs, Elizabeth Woodcock, a practice management consultant in Atlanta, GA, reports that value-based payments might account for 1% to 3% of income in an average practice—an amount that may not cover the costs of the personnel, equipment, and data processing needed to qualify for the programs. Doctors, especially those with small practices, often need help with creating IT systems, and companies are being established to help meet these needs.

Primary care physicians (PCPs) are the current focus of value-based programs, and specialists are not expected to be rewarded by ACOs. When offering referrals, however, some PCPs may look for specialists with high value-based scores, and specialists with low scores may be barred from participation in some narrow networks.

Page L. Medscape website. www.medscape.com/viewarticle/848306. October 8, 2015.

Related Items
Value Propositions - August 2017
VBCR - August 2017, Vol 6, No 3 published on August 23, 2017 in Value Propositions
Value Propositions - June 2017
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Value Propositions
Value Propositions - April 2017
VBCR - April 2017, Vol 6, No 1 published on May 3, 2017 in Value Propositions
Value Propositions - December 2016
VBCR - December 2016, Vol 5, No 6 published on January 5, 2017 in Value Propositions
Value Propositions - October 2016
VBCR - October 2016, Vol 5, No 5 published on November 2, 2016 in Value Propositions
Value Propositions - August 2016
VBCR - August 2016, Vol 5, No 4 published on August 25, 2016 in Value Propositions
Value Propositions - June 2016
VBCR - June 2016, Vol 5, No 3 published on July 7, 2016 in Value Propositions
Value Propositions - April 2016
VBCR - April 2016, Vol 5, No 2 published on May 14, 2016 in Value Propositions
Value Propositions - February 2016
VBCR - February 2016, Vol 5, No 1 published on March 15, 2016 in Value Propositions
Authorized Generic Version of Arava (Leflunomide) Now Available
VBCR - December 2015, Volume 4, No 6 published on December 15, 2015 in Value Propositions
Last modified: January 13, 2016
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology